Immunoglobulins, Intravenous
"Immunoglobulins, Intravenous" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Immunoglobulin preparations used in intravenous infusion, containing primarily IMMUNOGLOBULIN G. They are used to treat a variety of diseases associated with decreased or abnormal immunoglobulin levels including pediatric AIDS; primary HYPERGAMMAGLOBULINEMIA; SCID; CYTOMEGALOVIRUS infections in transplant recipients, LYMPHOCYTIC LEUKEMIA, CHRONIC; Kawasaki syndrome, infection in neonates, and IDIOPATHIC THROMBOCYTOPENIC PURPURA.
Descriptor ID |
D016756
|
MeSH Number(s) |
D12.776.124.486.485.114.619.393.536 D12.776.124.486.485.114.632 D12.776.124.790.651.114.632 D12.776.377.715.548.114.632
|
Concept/Terms |
Immunoglobulins, Intravenous- Immunoglobulins, Intravenous
- Intravenous IG
- Intravenous Antibodies
- IVIG
- Immune Globulin, Intravenous
- Intravenous Immune Globulin
- Antibodies, Intravenous
- Intravenous Immunoglobulins
- IV Immunoglobulins
- Immunoglobulins, IV
Intravenous Immunoglobulins, Human- Intravenous Immunoglobulins, Human
- Human Intravenous Immunoglobulins
- Immunoglobulins, Human Intravenous
- Immune Globulin Intravenous (Human)
- Immunoglobulins, Intravenous, Human
|
Below are MeSH descriptors whose meaning is more general than "Immunoglobulins, Intravenous".
Below are MeSH descriptors whose meaning is more specific than "Immunoglobulins, Intravenous".
This graph shows the total number of publications written about "Immunoglobulins, Intravenous" by people in this website by year, and whether "Immunoglobulins, Intravenous" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 1 | 1 | 2 |
1995 | 2 | 1 | 3 |
1996 | 1 | 3 | 4 |
2000 | 3 | 0 | 3 |
2001 | 1 | 1 | 2 |
2002 | 2 | 0 | 2 |
2003 | 2 | 1 | 3 |
2005 | 1 | 3 | 4 |
2006 | 3 | 0 | 3 |
2007 | 0 | 2 | 2 |
2008 | 1 | 1 | 2 |
2009 | 1 | 7 | 8 |
2010 | 3 | 3 | 6 |
2011 | 3 | 6 | 9 |
2012 | 2 | 1 | 3 |
2013 | 0 | 1 | 1 |
2014 | 2 | 2 | 4 |
2015 | 2 | 1 | 3 |
2016 | 2 | 1 | 3 |
2017 | 1 | 3 | 4 |
2018 | 4 | 0 | 4 |
2019 | 6 | 4 | 10 |
2020 | 3 | 4 | 7 |
2021 | 3 | 4 | 7 |
2022 | 1 | 4 | 5 |
2023 | 0 | 6 | 6 |
2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Immunoglobulins, Intravenous" by people in Profiles.
-
Design of the STRIVE-IPF trial- study of therapeutic plasma exchange, rituximab, and intravenous immunoglobulin for acute exacerbations of idiopathic pulmonary fibrosis. BMC Pulm Med. 2024 Mar 20; 24(1):143.
-
Blinatumomab Therapy Is Associated with Favorable Outcomes after Allogeneic Hematopoietic Cell Transplantation in Pediatric Patients with B Cell Acute Lymphoblastic Leukemia. Transplant Cell Ther. 2024 Feb; 30(2):217-227.
-
Pentoxifylline for treatment of sepsis and necrotising enterocolitis in neonates. Cochrane Database Syst Rev. 2023 06 20; 6:CD004205.
-
Viral Coinfections in Kawasaki Disease: A Meta-analysis. Hosp Pediatr. 2023 Jun 01; 13(6):e153-e169.
-
Variation in Early Anakinra Use and Short-Term Outcomes in Multisystem Inflammatory Syndrome in Children. Arthritis Rheumatol. 2023 08; 75(8):1466-1476.
-
The use of neutrophil-lymphocyte ratio for the prediction of refractory disease and coronary artery lesions in patients with Kawasaki disease. Cardiol Young. 2023 Aug; 33(8):1409-1417.
-
Thalidomide as an Effective Treatment in Sideroblastic Anemia, Immunodeficiency, Periodic Fevers, and Developmental Delay (SIFD). J Clin Immunol. 2023 05; 43(4):780-793.
-
Therapeutic Response in Pediatric Neuromyelitis Optica Spectrum Disorder. Neurology. 2023 02 28; 100(9):e985-e994.
-
2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Kawasaki Disease. Arthritis Care Res (Hoboken). 2022 04; 74(4):538-548.
-
2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Kawasaki Disease. Arthritis Rheumatol. 2022 04; 74(4):586-596.